Can you assist with product registration?

Yes, our professional team is responsible for registration and can provide necessary documents and samples.

Where is the company located?

The company is located at No. 1 Ruiyang Road, Yiyuan, Zibo, Shandong, China.

What is the main port for export?

The nearest port for export is Qingdao Port.

Reyoung Pharmaceutical Gentamycin Sulfate 80mg/2ml Pharmaceutical Injection

Name: Reyoung Pharmaceutical Gentamycin Sulfate 80mg/2ml Pharmaceutical Injection
Brand: REYOUNG PHARMACEUTICAL CO., LTD.
SKU: 787595722

Shandong, ChinaREYOUNG PHARMACEUTICAL CO., LTD.

US$0.15

10,000 box

Sample price:US$0.15/box.Request sample

Product profile

Customization

Available

Application

Injection

Usage Mode

For external use

Model NO.

80mg/2ml

Suitable for

Elderly, All

State

Liquid

Shape

Liquid

Type

Organic Chemicals

Pharmaceutical Technology

Chemical Synthesis

Drug Reg./Approval No.

Lu20160062

Drug Ad Approval No.

Lu20160062

Transport Package

Carton

Specification

80mg/2ml

Trademark

Reyoung

Origin

China

Production Capacity

5millions

Key features

Global Market Presence: Marketed in over 80 countries with 35 years of export experience.

International Certifications: Passed MOH inspections in multiple countries and holds ISO9001, ISO14001, OHS18001 certifications.

Massive Production Capacity: Annual capacity includes 2 billion vials of powder injection and 500 million ampoules of liquid injection.

OEM and ODM Services: Accepts contract manufacturing and offers both OEM and ODM services.

Comprehensive Product Range: Covers antibiotics, analgesics, vitamins, anti-cancer, and cardiovascular drugs including APIs.

Professional Registration Team: Dedicated team provides necessary documents and samples for product registration.

Established Manufacturer: Company established in 1966 with 5000 staff and 30 workshops.

Competitive Pricing: Offers high-quality products with very competitive pricing.

Company profile

REYOUNG PHARMACEUTICAL CO., LTD.

Shandong, China

CertifiedBusiness Type: Manufacturer/Factory & Trading Company CertifiedR&D Capacity: ODM Service Available & OEM Service AvailableExport Year: 1997-01-01 CertifiedNearest Port: Qingdao PortAverage Response Time: ≤18h CertifiedTerms of Payment: LC, T/T, D/P

AI-Powered supplier vetting

SummaryREYOUNG PHARMACEUTICAL CO., LTD. is a China-based limited company established in 1998, with 4,950 employees and operations in Shandong. The supplier reports ISO 9001, ISO 14001, and OHSAS 18001 certifications, more than 10 production lines, 50 quality-control staff, and 370 years of combined R&D-engineer experience. Its stated manufacturing portfolio includes sterile raw materials, powders and liquids for injection, tablets, and capsules, with reported annual production above the stated threshold. The company identifies three factories, an extensive manufacturing area, international business since 1997, and export markets across South America, Africa, Southeast Asia, and the Middle East. Trade records show transactions involving India, Bolivia, and Vietnam, including cefotaxime-related products. Evidence is insufficient to assess after-sales service, financial credibility, innovation output, or customization capability. Customer-case evidence is limited to named buyers and trade records.

Supplier typeThe supplier is identified as a combined business entity and a limited company headquartered in Shandong, China. Its business scope is health and medicine, with products including sterile raw materials, injectable products, tablets, and capsules, supporting classification as a pharmaceutical manufacturer and distributor.

CertificationsThe supplier explicitly reports ISO 9001:2015, ISO 14001:2015, and OHSAS 18001:2007 certificates, and separately describes itself as GMP and ISO authenticated. These stated certifications provide direct evidence of formal quality, environmental, and occupational-health management systems.

Production capacityProduction capacity is supported by more than 10 production lines, three factories, a reported manufacturing area of 1,000,000 square meters, and stated annual output across small-volume injections, powder injections, tablets, and capsules. The supplier also reports annual production above the stated threshold, indicating substantial multi-form pharmaceutical manufacturing capability.

Client casesTrade records identify transactions involving STERILE INDIA PRIVATE LIMITED, HEREDIA ARACENA RENY EVELIN, and a Vietnam-related registration, with products including cefotaxime-related material and oral rehydration products. These records demonstrate some international commercial activity, but the evidence is limited and does not establish long-term customer performance or a broad verified customer portfolio.

Product Q&A

Q:What is the company's production capacity?

Annual capacity includes 2 billion vials of powder injection, 500 million ampoules of liquid injection, 10 billion tablets, 1 billion capsules, 100 million bags of granules, and 2000 tons of API.

Q:Do you offer OEM or ODM services?

Yes, we accept OEM, contract manufacturing, and ODM services.

Q:What certifications does the company hold?

We have passed MOH inspections in Ethiopia, Yemen, Iraq, Ghana, Pakistan, Nigeria, Kenya, Kazakhstan, Uganda, Congo, Tanzania, and hold ISO9001, ISO14001, and OHS18001 certifications.

Q:How long is the lead time for orders?

The average lead time is 1-3 months for both peak and off-peak seasons.

Q:What payment terms do you accept?

We accept LC, T/T, and D/P payment terms.